South Africa: Vaccine May Be Ready in Early 2021, Neighbourhood Creates Space for Self-Isolation, and Oxygen Supply Shortage Looms in Gauteng

Professor Shabir-Madhi explains the vaccine trial to a patient (file photo).
analysis

On Thursday, it was predicted that the Covid-19 vaccine being trialled in South Africa may be ready by early 2021. In Gauteng, the short supply of oxygen has raised questions over how much planning and preparation was done during lockdown. Meanwhile, amaBhungane has revealed that a bungled tender could have provided a lifeline of food parcels to Sassa grant recipients before and during lockdown. In Cape Town, a neighbourhood has pulled together to provide a safe space for people with Covid-19 to isolate.

Scroll through the gallery below to view the latest Covid-19 numbers available on 9 July at the district level. All maps are sourced from provincial health departments; however, KwaZulu-Natal, Gauteng and Limpopo did not provide an update by the time of publishing:

The Covid-19 vaccine currently being trialled in South Africa could be ready in the first quarter of 2021 - but this, of course, depends on the results of the clinical trials, said the principal investigator of Oxford Covid-19 Vaccine Trial in South Africa, Professor Shabir Madhi. He was providing an update on the trial during a World Health Organisation press briefing on Thursday 9 July. He said that in the...

More From: Daily Maverick

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.